Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 118

1.

Vitamin D enhances responses to interferon-β in MS.

Feng X, Wang Z, Howlett-Prieto Q, Einhorn N, Causevic S, Reder AT.

Neurol Neuroimmunol Neuroinflamm. 2019 Oct 3;6(6):e622. doi: 10.1212/NXI.0000000000000622. Print 2019 Nov.

2.

Early Life Stress Restricts Translational Reactivity in CA3 Neurons Associated With Altered Stress Responses in Adulthood.

Marrocco J, Gray JD, Kogan JF, Einhorn NR, O'Cinneide EM, Rubin TG, Carroll TS, Schmidt EF, McEwen BS.

Front Behav Neurosci. 2019 Jul 11;13:157. doi: 10.3389/fnbeh.2019.00157. eCollection 2019.

3.

Epigenetic intersection of BDNF Val66Met genotype with premenstrual dysphoric disorder transcriptome in a cross-species model of estradiol add-back.

Marrocco J, Einhorn NR, Petty GH, Li H, Dubey N, Hoffman J, Berman KF, Goldman D, Lee FS, Schmidt PJ, McEwen BS.

Mol Psychiatry. 2018 Oct 24. doi: 10.1038/s41380-018-0274-3. [Epub ahead of print]

PMID:
30356121
4.

[German Translation of the COPD Self-Efficacy Scale: Development and Validation of a Short Form].

Müller K, Niermann C, Einhorn N, Kotschy-Lang N, Wagner P.

Psychother Psychosom Med Psychol. 2017 May;67(5):185-194. doi: 10.1055/s-0042-121803. Epub 2017 May 10. German.

PMID:
28493244
5.

Gain of chromosome 3q is an early and consistent genetic aberration in carcinomas of the vulva.

Stoltzfus P, Heselmeyer-Haddad K, Castro J, White N, Silfverswärd C, Sjövall K, Einhorn N, Tryggvason K, Auer G, Ried T, Nordström B.

Int J Gynecol Cancer. 2005 Jan-Feb;15(1):120-6.

6.

A systematic overview of radiation therapy effects in ovarian cancer.

Einhorn N, Tropé C, Ridderheim M, Boman K, Sorbe B, Cavallin-Ståhl E.

Acta Oncol. 2003;42(5-6):562-6. Review.

PMID:
14596514
7.

A systematic overview of radiation therapy effects in uterine cancer (corpus uteri).

Einhorn N, Tropé C, Ridderheim M, Boman K, Sorbe B, Cavallin-Ståhl E.

Acta Oncol. 2003;42(5-6):557-61. Review.

PMID:
14596513
8.

A systematic overview of radiation therapy effects in cervical cancer (cervix uteri).

Einhorn N, Tropé C, Ridderheim M, Boman K, Sorbe B, Cavallin-Ståhl E.

Acta Oncol. 2003;42(5-6):546-56. Review.

PMID:
14596512
9.

Radiotherapy techniques in current use in Sweden.

Möller TR, Ceberg J, Einhorn N, Lindholm C, Nylén U, Svensson H; SBU Survey Group.

Acta Oncol. 2003;42(5-6):376-86.

PMID:
14596501
10.

Radiotherapy and cancer care in Sweden.

Möller TR, Einhorn N, Lindholm C, Ringborg U, Svensson H; SBU Survey Group.

Acta Oncol. 2003;42(5-6):366-75.

PMID:
14596500
11.

The Swedish Council on Technology Assessment in Health Care (SBU) systematic overview of radiotherapy for cancer including a prospective survey of radiotherapy practice in Sweden 2001--summary and conclusions.

Ringborg U, Bergqvist D, Brorsson B, Cavallin-Ståhl E, Ceberg J, Einhorn N, Frödin JE, Järhult J, Lamnevik G, Lindholm C, Littbrand B, Norlund A, Nylén U, Rosén M, Svensson H, Möller TR.

Acta Oncol. 2003;42(5-6):357-65. Review.

PMID:
14596499
12.

The significance of serum CA 125 elevation in malignant and nonmalignant diseases.

Sjövall K, Nilsson B, Einhorn N.

Gynecol Oncol. 2002 Apr;85(1):175-8.

PMID:
11925140
13.

Laminin-5 gamma 2 chain as an invasivity marker for uni- and multifocal lesions in the lower anogenital tract.

Nordström B, Einhorn N, Silfverswärd C, Sjövall K, Tryggvason K, Auer G.

Int J Gynecol Cancer. 2002 Jan-Feb;12(1):105-9.

PMID:
11860544
14.

Phase II study of mitomycin-C and cisplatin in disseminated, squamous cell carcinoma of the uterine cervix. A European Organization for Research and Treatment of Cancer (EORTC) Gynecological Cancer Group study.

Wagenaar HC, Pecorelli S, Mangioni C, van der Burg ME, Rotmensz N, Anastasopoulou A, Zola P, Veenhof CH, Lacave AJ, Neijt JP, van Oosterom AT, Einhorn N, Vermorken JB.

Eur J Cancer. 2001 Sep;37(13):1624-8.

PMID:
11527687
15.

D-TRP-6-LHRH (Triptorelin) is not effective in ovarian carcinoma: an EORTC Gynaecological Cancer Co-operative Group Study.

Duffaud F, van der Burg ME, Namer M, Vergote I, Willemse PHB, ten Bokkel Huinink W, Guastalla JP, Nooij, Kerbrat P, Piccart M, Tumolo S, Favalli G, van der Vange N, Lacave AJ, Wils J, Splinter TA, Einhorn N, Roozendaal KJ, Rosso R, Vermorken JB.

Anticancer Drugs. 2001 Feb;12(2):159-62.

PMID:
11261890
16.

Prognostic significance of cell cycle proteins and genomic instability in borderline, early and advanced stage ovarian carcinomas.

Blegen H, Einhorn N, Sjövall K, Roschke A, Ghadimi BM, McShane LM, Nilsson B, Shah K, Ried T, Auer G.

Int J Gynecol Cancer. 2000 Nov;10(6):477-487.

PMID:
11240718
17.

Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma.

Vergote I, De Brabanter J, Fyles A, Bertelsen K, Einhorn N, Sevelda P, Gore ME, Kaern J, Verrelst H, Sjövall K, Timmerman D, Vandewalle J, Van Gramberen M, Tropé CG.

Lancet. 2001 Jan 20;357(9251):176-82.

PMID:
11213094
18.

Long-term follow-up of the Stockholm screening study on ovarian cancer.

Einhorn N, Bast R, Knapp R, Nilsson B, Zurawski V Jr, Sjövall K.

Gynecol Oncol. 2000 Dec;79(3):466-70.

PMID:
11104621
19.

Is there place for radiotherapy in the treatment of advanced ovarian cancer?

Einhorn N, Lundell M, Nilsson B, Ragnarsson-Olding B, Sjövall K.

Radiother Oncol. 1999 Dec;53(3):213-8.

PMID:
10660201
20.

Analysis of postoperative vaginal vault radiotherapy of stage I endometrial cancer with different radionuclides.

Ryberg M, Hamed AF, Nilsson B, Rudén BI, Einhorn N.

Acta Oncol. 1998;37(1):61-3.

PMID:
9572655
21.

Age is not a limiting factor for radical radiotherapy in pelvic malignancies.

Pignon T, Horiot JC, Bolla M, van Poppel H, Bartelink H, Roelofsen F, Pene F, Gerard A, Einhorn N, Nguyen TD, Vanglabbeke M, Scalliet P.

Radiother Oncol. 1997 Feb;42(2):107-20.

PMID:
9106920
22.

Ovarian cancer--a challenging disease.

Einhorn N.

Gynecol Oncol. 1996 Oct;63(1):10-3. No abstract available.

PMID:
8898160
23.

Pitfalls of endoscopic carpal tunnel release.

Einhorn N, Leddy JP.

Orthop Clin North Am. 1996 Apr;27(2):373-80. Review.

PMID:
8614585
24.

Ovarian cancer.

Einhorn N.

Acta Oncol. 1996;35 Suppl 7:86-92.

PMID:
9154100
25.

Uterine cancer (corpus uteri).

Einhorn N.

Acta Oncol. 1996;35 Suppl 7:81-5.

PMID:
9154099
26.

Cervical cancer (cervix uteri).

Einhorn N.

Acta Oncol. 1996;35 Suppl 7:75-80.

PMID:
9154098
27.

Biological malignancy grading in early-stage ovarian carcinoma.

Auer G, Einhorn N, Nilsson B, Silfverswärd C, Sjövall K.

Acta Oncol. 1996;35 Suppl 8:93-8.

PMID:
9073054
28.

Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers.

Skates SJ, Xu FJ, Yu YH, Sjövall K, Einhorn N, Chang Y, Bast RC Jr, Knapp RC.

Cancer. 1995 Nov 15;76(10 Suppl):2004-10.

PMID:
8634992
29.

Different types of rupture of the tumor capsule and the impact on survival in early ovarian carcinoma.

Sjövall K, Nilsson B, Einhorn N.

Int J Gynecol Cancer. 1994 Sep;4(5):333-336.

PMID:
11578428
30.

Paget's disease of the vulva: the Radiumhemmet series 1975-1990.

Baehrendtz H, Einhorn N, Pettersson F, Silfverswärd C.

Int J Gynecol Cancer. 1994 Jan;4(1):1-6.

PMID:
11578378
31.

[Early diagnosis is important in ovarian cancer].

Einhorn N.

Lakartidningen. 1993 Oct 13;90(41):3564-5. Swedish. No abstract available.

PMID:
8231502
32.

Is there an altered steroid profile in patients with endometrial carcinoma?

Möllerström G, Carlström K, Lagrelius A, Einhorn N.

Cancer. 1993 Jul 1;72(1):173-81.

PMID:
8508403
33.

Treatment of ovarian cancer: the state of the art.

Einhorn N.

Med Oncol Tumor Pharmacother. 1993;10(3):139-42. Review.

PMID:
8264259
34.

Ovarian cancer. Early diagnosis and screening.

Einhorn N.

Hematol Oncol Clin North Am. 1992 Aug;6(4):843-50. Review.

PMID:
1500389
35.

Prospective evaluation of serum CA 125 levels for early detection of ovarian cancer.

Einhorn N, Sjövall K, Knapp RC, Hall P, Scully RE, Bast RC Jr, Zurawski VR Jr.

Obstet Gynecol. 1992 Jul;80(1):14-8.

PMID:
1603484
36.

Clinical relevance of the CA 125 assay in monitoring of ovarian cancer patients.

Hising C, Anjegård IM, Einhorn N.

Am J Clin Oncol. 1991 Apr;14(2):111-4.

PMID:
2028919
37.

Treatment of advanced condylomata acuminata with semi-purified and purified human leukocyte interferon.

Einhorn N, Ling P, Secher D, Strander H.

Acta Oncol. 1991;30(3):343-5.

PMID:
1645172
38.

Risk factors and etiology in gynecologic cancer.

Einhorn N.

Curr Opin Oncol. 1990 Oct;2(5):857-63. Review. No abstract available.

PMID:
1965695
39.
40.
41.
42.
44.
45.

The role of preoperative radiotherapy in the treatment of carcinoma of the endometrium.

Einhorn N.

Cancer Treat Res. 1989;49:53-61. Review. No abstract available.

PMID:
2577202
46.

Hormone receptor analysis in endometrial cytologic samples collected with the Gynoscann device.

Costa MM, Einhorn N, Humla S, Skoog L.

Anal Quant Cytol Histol. 1988 Jun;10(3):211-3.

PMID:
3044381
47.

An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinoma.

Zurawski VR Jr, Knapp RC, Einhorn N, Kenemans P, Mortel R, Ohmi K, Bast RC Jr, Ritts RE Jr, Malkasian G.

Gynecol Oncol. 1988 May;30(1):7-14.

PMID:
2452773
48.

A phase II study on escalating interferon doses in advanced ovarian carcinoma.

Einhorn N, Ling P, Einhorn S, Strander H.

Am J Clin Oncol. 1988 Feb;11(1):3-6.

PMID:
3277373
49.
50.

Symptomatology of ovarian cancer.

Flam F, Einhorn N, Sjövall K.

Eur J Obstet Gynecol Reprod Biol. 1988 Jan;27(1):53-7.

PMID:
3338609

Supplemental Content

Loading ...
Support Center